Position in EOLS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$888,861
+$376,094 QoQ
Shares Held
128,078
+2.7% QoQ
Ownership
0.194%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 158 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $225,769,469 across 37 Drug Manufacturers - Specialty & Generic names. EOLS ranks #24 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
1,974,908 | $48,602,485 | |
| 2 | ZTS |
Zoetis Inc.
|
400,665 | $28,791,786 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,402,650 | $22,484,479 | |
| 4 | VTRS |
Viatris Inc
|
1,368,433 | $21,730,716 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
27,122 | $14,695,513 | |
| 6 | PRGO |
PERRIGO Co plc
|
1,369,736 | $14,231,557 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
79,655 | $13,425,053 | |
| 8 | HLN |
Haleon plc
|
1,151,189 | $10,740,593 |
All Filings in EOLS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $888,861 | 128,078 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $512,767 | 124,761 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $591,770 | 88,988 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $199,721 | 32,528 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $150,509 | 16,342 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||